Related Experiment Videos
Systemic corticosteroids in the phenytoin hypersensitivity syndrome
S Chopra1, N J Levell, G Cowley
1Department of Dermatology, University College London Hospitals, U.K.
The British Journal of Dermatology
|June 1, 1996
Summary
Systemic corticosteroids effectively resolved phenytoin hypersensitivity syndrome (PHS) symptoms in a patient. Symptoms recurred upon withdrawal and remitted again upon readministration, suggesting a therapeutic role for corticosteroids in PHS management.
Area of Science:
- Clinical Medicine
- Pharmacology
- Dermatology
Background:
- Phenytoin hypersensitivity syndrome (PHS) is a severe adverse drug reaction.
- Established treatment guidelines for PHS are lacking.
Observation:
- A patient presented with classic PHS features: fever, erythroderma, edema, facial pustules, and abnormal liver function.
- The patient's condition was monitored during corticosteroid therapy.
Findings:
- Systemic corticosteroids led to the complete resolution of all PHS symptoms.
- Discontinuation of corticosteroids resulted in symptom recurrence.
- Reinstitution of corticosteroids achieved a second remission, confirming their efficacy.
Implications:
- This case suggests a potential therapeutic role for systemic corticosteroids in managing phenytoin hypersensitivity syndrome.
- Further research is warranted to establish evidence-based treatment protocols for PHS.
- Clinicians should consider corticosteroids for severe PHS cases unresponsive to other measures.